Amgen Inc (NASDAQ:AMGN)
| 269.31 Delayed Data As of Sep 21 |  -2.05 / -0.76%Today’s Change | 211.71 Today|||52-Week Range 296.67 | +2.54% Year-to-Date |
Latest AMGN News | Press Releases
Today’s Trading
| Previous close | 271.46 |
| Today’s open | 272.07 |
| Day’s range | 267.70 - 272.48 |
| Volume | 2,437,213 |
| Average volume (3 months) | 2,585,672 |
| Market cap | $139.5B |
Data as of 4:00pm ET, 09/21/2023
Growth & Valuation
| Earnings growth (last year) | +17.80% |
| Earnings growth (this year) | +0.50% |
| Earnings growth (next 5 years) | +4.50% |
| Revenue growth (last year) | +0.40% |
| P/E ratio | 18.2 |
| Price/Sales | 5.45 |
| Price/Book | 38.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -0.55 | -0.73% |
| ---- | ||
| MRNAModerna Inc | -3.30 | -3.19% |
| BIIBBiogen | -1.60 | -0.61% |
Data as of 4:00pm ET, 09/21/2023
Financials
| Next reporting date | October 31, 2023 |
| EPS forecast (this quarter) | $4.74 |
| Annual revenue (last year) | $26.1B |
| Annual profit (last year) | $6.6B |
| Net profit margin | 25.11% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
